In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. 2002

Joseph L Wiemels, and Zhijian Xiao, and Patricia A Buffler, and Ana T Maia, and Xiaomei Ma, and Brian M Dicks, and Martyn T Smith, and Luoping Zhang, and James Feusner, and John Wiencke, and Kathy Pritchard-Jones, and Helena Kempski, and Mel Greaves
Laboratory for Molecular Epidemiology, Department of Epidemiology and Biostatistics, University of California San Francisco 94143-0560, USA. jwiemels@epi.ucsf.edu

Recent reports have established the prenatal origin of leukemia translocations and resultant fusion genes in some patients, including MLL-AF4 translocations in infants and TEL-AML1 translocations in children. We now report evidence for the prenatal origin of a translocation in childhood acute myeloid leukemia (AML). The t(8;21) AML1-ETO translocations were sequenced at the genomic level in 10 diagnostic leukemia samples from children with available neonatal Guthrie blood spots. Clonotypic genomic AML1-ETO sequences were detected in the Guthrie spots for 5 individuals, providing unambiguous evidence of prenatal origin in these cases. Two of these patients were older than 10 years of age at diagnosis, indicative of a protracted postnatal latency. Three of the patients were assessed for the persistence of genomic fusion sequences in complete clinical remission samples and were found to be positive. These data indicate that t(8;21) in childhood AML can arise in utero, possibly as an initiating event in childhood AML, and may establish a long-lived or stable parental clone that requires additional secondary genetic alterations to cause leukemia.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002891 Chromosomes, Human, Pair 21 A specific pair of GROUP G CHROMOSOMES of the human chromosome classification. Chromosome 21
D002898 Chromosomes, Human, Pair 8 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 8
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075142 RUNX1 Translocation Partner 1 Protein A transcriptional co-repressor that contains a MYND-type zinc finger (MYND DOMAIN) at its C-terminal and functions as a homo-oligomer. It associates with DNA-binding transcription factors, other repressor proteins, and HISTONE ACETYLTRANSFERASES to repress expression of genes involved in cell growth and differentiation such as MATRIX METALLOPROTEINASE 7 and TCF12. A CHROMOSOMAL TRANSLOCATION involving the RUNX1T1 and CORE BINDING FACTOR ALPHA 2 SUBUNIT (RUNX1) genes frequently occurs in cells of leukemia patients; the resulting fusion protein (AML1-ETO or RUNX1-RUNX1T1) plays a critical role in leukemogenesis. Eight Twenty One Protein,RUNX1T1 Protein

Related Publications

Joseph L Wiemels, and Zhijian Xiao, and Patricia A Buffler, and Ana T Maia, and Xiaomei Ma, and Brian M Dicks, and Martyn T Smith, and Luoping Zhang, and James Feusner, and John Wiencke, and Kathy Pritchard-Jones, and Helena Kempski, and Mel Greaves
August 1994, Leukemia & lymphoma,
Joseph L Wiemels, and Zhijian Xiao, and Patricia A Buffler, and Ana T Maia, and Xiaomei Ma, and Brian M Dicks, and Martyn T Smith, and Luoping Zhang, and James Feusner, and John Wiencke, and Kathy Pritchard-Jones, and Helena Kempski, and Mel Greaves
February 2017, Experimental hematology,
Joseph L Wiemels, and Zhijian Xiao, and Patricia A Buffler, and Ana T Maia, and Xiaomei Ma, and Brian M Dicks, and Martyn T Smith, and Luoping Zhang, and James Feusner, and John Wiencke, and Kathy Pritchard-Jones, and Helena Kempski, and Mel Greaves
March 2002, Haematologica,
Joseph L Wiemels, and Zhijian Xiao, and Patricia A Buffler, and Ana T Maia, and Xiaomei Ma, and Brian M Dicks, and Martyn T Smith, and Luoping Zhang, and James Feusner, and John Wiencke, and Kathy Pritchard-Jones, and Helena Kempski, and Mel Greaves
May 2010, Cancer research,
Joseph L Wiemels, and Zhijian Xiao, and Patricia A Buffler, and Ana T Maia, and Xiaomei Ma, and Brian M Dicks, and Martyn T Smith, and Luoping Zhang, and James Feusner, and John Wiencke, and Kathy Pritchard-Jones, and Helena Kempski, and Mel Greaves
January 2016, Blood,
Joseph L Wiemels, and Zhijian Xiao, and Patricia A Buffler, and Ana T Maia, and Xiaomei Ma, and Brian M Dicks, and Martyn T Smith, and Luoping Zhang, and James Feusner, and John Wiencke, and Kathy Pritchard-Jones, and Helena Kempski, and Mel Greaves
April 2013, Oncogene,
Joseph L Wiemels, and Zhijian Xiao, and Patricia A Buffler, and Ana T Maia, and Xiaomei Ma, and Brian M Dicks, and Martyn T Smith, and Luoping Zhang, and James Feusner, and John Wiencke, and Kathy Pritchard-Jones, and Helena Kempski, and Mel Greaves
April 2001, Nature medicine,
Joseph L Wiemels, and Zhijian Xiao, and Patricia A Buffler, and Ana T Maia, and Xiaomei Ma, and Brian M Dicks, and Martyn T Smith, and Luoping Zhang, and James Feusner, and John Wiencke, and Kathy Pritchard-Jones, and Helena Kempski, and Mel Greaves
October 2022, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,
Joseph L Wiemels, and Zhijian Xiao, and Patricia A Buffler, and Ana T Maia, and Xiaomei Ma, and Brian M Dicks, and Martyn T Smith, and Luoping Zhang, and James Feusner, and John Wiencke, and Kathy Pritchard-Jones, and Helena Kempski, and Mel Greaves
February 1993, Blood,
Joseph L Wiemels, and Zhijian Xiao, and Patricia A Buffler, and Ana T Maia, and Xiaomei Ma, and Brian M Dicks, and Martyn T Smith, and Luoping Zhang, and James Feusner, and John Wiencke, and Kathy Pritchard-Jones, and Helena Kempski, and Mel Greaves
May 2012, Leukemia,
Copied contents to your clipboard!